PG
JAZZ icon

PEAK6 Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

PEAK6 Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,500
Closed -$1.13M – 4632
2018
Q1 		$1.13M Buy
+7,500
New +$1.1M ﹤0.01% 1851
2017
Q4 		– Sell
-13,100
Closed -$1.92M – 4424
2017
Q3 		$1.92M Sell
13,100
-12,100
-48% -$1.83M 0.01% 1424
2017
Q2 		$3.92M Buy
25,200
+22,100
+713% +$3.38M 0.02% 871
2017
Q1 		$450K Sell
3,100
-400
-11% -$52.1K ﹤0.01% 2344
2016
Q4 		$382K Sell
3,500
-9,700
-73% -$1.08M ﹤0.01% 2762
2016
Q3 		$1.6M Buy
13,200
+9,900
+300% +$1.33M 0.01% 1421
2016
Q2 		$466K Sell
3,300
-2,500
-43% -$369K ﹤0.01% 2416
2016
Q1 		$757K Sell
5,800
-8,200
-59% -$1.02M 0.01% 1927
2015
Q4 		$1.97M Sell
14,000
-11,900
-46% -$1.65M 0.01% 1357
2015
Q3 		$3.44M Sell
25,900
-6,200
-19% -$1.07M 0.02% 1146
2015
Q2 		$5.65M Buy
32,100
+5,800
+22% +$1.04M 0.03% 755
2015
Q1 		$4.54M Buy
26,300
+22,700
+631% +$3.9M 0.03% 733
2014
Q4 		$589K Sell
3,600
-3,400
-49% -$564K ﹤0.01% 2432
2014
Q3 		$1.12M Sell
7,000
-11,100
-61% -$1.71M 0.01% 1718
2014
Q2 		$2.66M Sell
18,100
-34,800
-66% -$4.83M 0.03% 888
2014
Q1 		$7.34M Buy
52,900
+30,200
+133% +$4.55M 0.06% 406
2013
Q4 		$2.87M Sell
22,700
-78,100
-77% -$8.08M 0.02% 1138
2013
Q3 		$4.64M Buy
+100,800
New +$8.13M 0.03% 822

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

PEAK6 Group's JAZZ Position: Q4 2017 in Review

PEAK6 Group sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2017, closing a stake of 30,276 shares — an estimated $4.43M sold.

PEAK6 Group first reported a position in JAZZ in Q1 2014 and held it in 11 quarters. The position peaked at $8.06M in Q1 2014. 323 funds tracked by Wall St. Rank hold JAZZ as of Q4 2017.

  • PEAK6 Group reported no remaining Jazz Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 30,276 Jazz Pharmaceuticals shares in Q4 2017, an estimated $4.43M.
  • PEAK6 Group first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 11 quarters.
  • PEAK6 Group's Jazz Pharmaceuticals position peaked at $8.06M in Q1 2014.
  • 323 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.